Hillhurst Biopharmaceuticals announces completion of last patient last visit in Phase 1 clinical trial of HBI-002
SAN DIEGO, CA (May 23, 2023) Hillhurst Biopharmaceuticals, ...
Drops and drugs for diabetic vison loss
Eye injections are the only way to treat diabetic ...
Hillhurst Bio Turns Gas from Poisonous to Therapeutic
When most people think of carbon monoxide, they envision odorless ...
Hillhurst Biopharmaceuticals announces first subject dosed in Phase 1 clinical trial of HBI-002
SAN DIEGO, CA (July 26, 2022) Hillhurst Biopharmaceuticals, ...
Deadly gas could treat diabetic blindness, according to AU study
Carbon monoxide from engine exhaust kills hundreds of people ...
Hillhurst Biopharmaceuticals Receives Study May Proceed Letter From US FDA to Initiate Phase 1 Clinical Trial of HBI-002
SAN DIEGO, CA (April 23, 2021) Hillhurst Biopharmaceuticals, Inc. ...
Hillhurst Biopharmaceuticals Receives Funding For Development Of HBI-002 For Treatment of Ulcerative Colitis
SAN DIEGO, CA (March 25, 2021) Hillhurst Biopharmaceuticals, Inc., ...
Hillhurst Biopharmaceuticals Receives Phase 2 SBIR Funding For Clinical Development Of HBI-002 For Prevention Of Vaso-Occlusive Crises in Sickle Cell Disease.
SAN DIEGO, CA (Nov. 28, 2018) Hillhurst Biopharmaceuticals, Inc., ...
Hillhurst Biopharmaceuticals Receives SBIR Funding For Development Of HBI-002 For Prevention Of Delayed Graft Function In Kidney Transplantation
SAN DIEGO, CA (June 14, 2017) Hillhurst Biopharmaceuticals, Inc., ...